Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives: Analysis of Data from Three Randomized, Single-Dose, Pharmacokinetic Studies

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 613-623

Adis International

Access to resources Recommend Favorite

Elimination Half-Lives of Selected Polychlorinated Dibenzodioxins and Dibenzofurans in Breast-Fed Human Infants

By Leung Hon-Wing   Kerger Brent   Paustenbach Dennis  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 6, 2006-04 ,pp. : 437-443

Taylor & Francis Ltd

Access to resources Recommend Favorite

All Half-Lives Are Wrong, But Some Half-Lives Are Useful

By Wright J.G.   Boddy A.V.  

Clinical Pharmacokinetics, Vol. 40, Iss. 4, 2001-01 ,pp. : 237-244

Adis International

Access to resources Recommend Favorite

Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis

By Strampel William  

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 755-763

Adis International

Access to resources Recommend Favorite

Application of Simple Mathematical Expressions to Relate Half-Lives of Drugs in Mice to Those in Humans

By  

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-01 ,pp. : 127-129

Bentham Science Publishers

Access to resources Recommend Favorite